Head and Neck Cancer in Southeast Asia: 2022 Incidence, Mortality, and Projections to 2050
The Laryngoscope · 2025-12 · 135 (12) · 4742-4753
DOI: 10.1002/lary.32450 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Laryngoscope, online erschienen am 23.07.2025. Verfasst von Jenny Chen und 22 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Division of Plastic and Reconstructive Surgery, Memorial Sloan Kettering Cancer Center, New York, New York, USA. Hauptthemen laut MEDLINE: Head and Neck Neoplasms. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 33 Literaturangaben. Gefördert von: National Cancer Institute, Prostate Cancer Foundation, National Heart, Lung, and Blood Institute.
Abstract (Originalsprache)
Objectives
To characterize the incidence, mortality, and disparities in head and neck cancer (HNC) across Southeast Asia (SEA) in 2022 and project trends to 2050 to inform cancer planning.
Methods
We conducted a population‐based analysis using 2022 Global Cancer Observatory data from 11 SEA countries. We analyzed cancers of the lip and oral cavity, salivary glands, oropharynx, nasopharynx, hypopharynx, larynx, and thyroid. Age‐standardized incidence and mortality rates (ASIR and ASMR) were calculated using the Segi‐Doll world standard. Projections to 2050 were based on demographic changes using UN World Population Prospects data, assuming stable incidence and mortality rates.
Results
Myanmar had the highest oral cancer rates (ASIR: 6.6 males, 2.6 females; ASMR: 3.9 males, 1.6 females). Elevated salivary gland cancer incidence was observed in Indonesia, the Philippines, and Singapore. Oropharyngeal cancers showed strong male predominance in Myanmar (ASIR ratio: 10:1). Nasopharyngeal cancer incidence in Brunei and Indonesia exceeded global averages (ASIR: 9.8 and 9.6 males). Projections to 2050 estimate 47,000 new male cases and 28,200 new female cases in Indonesia, with 30,600 male deaths and 12,200 female deaths. While SEA's overall ASIR for HNC (18.0) was comparable to the global average (18.9), the ASMR was significantly higher (9.5 vs. 5.3).
Conclusions
The rising burden of HNC in SEA highlights urgent disparities in incidence and mortality. Targeted prevention, early detection, and investment in cancer care systems are essential to mitigate future disease burden and improve outcomes. Level of Evidence Level III—Epidemiologic study using population‐based registry data.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Surgery, Division of Plastic and Reconstructive Surgery, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
- University of California San Diego, La Jolla, California, USA.
- College of Medicine, University of the Philippines, Manila, Philippines.
- Department of Radiation Oncology, Benavides Cancer Institute, University of Santo Tomas Hospital, Manila, Philippines.
- School of Medicine and Public Health, Ateneo de Manila University, Pasig, Philippines.
- Department of Medicine, NYC Health + Hospitals/Elmhurst, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
ORCID-Profile: James Fan Wu, Edward Christopher Dee
Förderung
- National Cancer Institute
- Prostate Cancer Foundation
- National Heart, Lung, and Blood Institute
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
Zitieren
APA
Chen, J., Selokar, A., Ho, F. D. V., Jacomina, L. E., Feliciano, E. J. G., Uy, J. M. A. L., Wu, J. F., Jain, U., Jain, B., Columbres, R. C., Treechairusame, T., Willmann, J., Ting, F. I. L., Iyengar, P., Moraes, F. Y., Gyawali, B., Tangco, E. D., Flores, J. A., Chua, M. L. K., …, & Dee, E. C. (2025). Head and Neck Cancer in Southeast Asia: 2022 Incidence, Mortality, and Projections to 2050. The Laryngoscope, 135(12), 4742-4753. https://doi.org/10.1002/lary.32450
Vancouver
Chen J, Selokar A, Ho FDV, Jacomina LE, Feliciano EJG, Uy JMAL, et al. Head and Neck Cancer in Southeast Asia: 2022 Incidence, Mortality, and Projections to 2050. The Laryngoscope. 2025;135(12):4742-4753. doi:10.1002/lary.32450
BibTeX
@article{Chen2025,
author = {Chen, Jenny and Selokar, Aryan and Ho, Frances Dominique V and Jacomina, Luisa E and Feliciano, Erin Jay G and Uy, Julianna Marie Angeline de Luna and Wu, James Fan and Jain, Urvish and Jain, Bhav and Columbres, Rod Carlo and Treechairusame, Teeradon and Willmann, Jonas and Ting, Frederic Ivan L and Iyengar, Puneeth and Moraes, Fabio Ynoe and Gyawali, Bishal and Tangco, Enrico D and Flores, Jerickson Abbie and Chua, Melvin L K and Estilo, Cherry and Mejia, Michael Benedict A and Lee, Nancy Y and Dee, Edward Christopher},
title = {Head and Neck Cancer in Southeast Asia: 2022 Incidence, Mortality, and Projections to 2050},
journal = {The Laryngoscope},
year = {2025},
volume = {135},
number = {12},
pages = {4742--4753},
doi = {10.1002/lary.32450}
}
EUVIMED